JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has issued a Pricing Supplement for its Dual Directional Trigger Performance Leveraged Upside Securities (Trigger PLUS) based on the MSCI Emerging Markets Index, with a maturity date of August 4, 2027. The Trigger PLUS, which do not pay interest and do not guarantee principal return, offer investors potential for leveraged upside performance of the underlying index, capped at a maximum upside payment, and an absolute return feature for a limited range of negative performance of the index. If the index depreciates by more than 20%, investors will lose a corresponding percentage of their principal. The securities are unsecured and unsubordinated obligations of JPMorgan Financial, guaranteed by JPMorgan Chase & Co., and...Show More

JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has issued a Pricing Supplement for its Dual Directional Trigger Performance Leveraged Upside Securities (Trigger PLUS) based on the MSCI Emerging Markets Index, with a maturity date of August 4, 2027. The Trigger PLUS, which do not pay interest and do not guarantee principal return, offer investors potential for leveraged upside performance of the underlying index, capped at a maximum upside payment, and an absolute return feature for a limited range of negative performance of the index. If the index depreciates by more than 20%, investors will lose a corresponding percentage of their principal. The securities are unsecured and unsubordinated obligations of JPMorgan Financial, guaranteed by JPMorgan Chase & Co., and are part of JPMorgan Financial's Medium-Term Notes, Series A program. The securities, which are not bank deposits and are not insured by any governmental agency, were priced on July 31, 2024, with an aggregate principal amount of $2,575,000. The securities will not be listed on any securities exchange, and secondary market trading may be limited. The offering involves risks, as detailed in the accompanying prospectus supplement and product supplement.